A citation-based method for searching scientific literature

Christine Garcia, C Bethan Powell. Obstet Gynecol Surv 2015
Times Cited: 3







List of co-cited articles
3 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Linkage of early-onset familial breast cancer to chromosome 17q21.
J M Hall, M K Lee, B Newman, J E Morrow, L A Anderson, B Huey, M C King. Science 1990
66

Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.
R Wooster, S L Neuhausen, J Mangion, Y Quirk, D Ford, N Collins, K Nguyen, S Seal, T Tran, D Averill. Science 1994
66

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
66

The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study.
Yakir Segev, Javaid Iqbal, Jan Lubinski, Jacek Gronwald, Henry T Lynch, Pal Moller, Parviz Ghadirian, Barry Rosen, Nadine Tung, Charmaine Kim-Sing,[...]. Gynecol Oncol 2013
62
33

Carcinoma of the Cervix Uteri.
M A Quinn, J L Benedet, F Odicino, P Maisonneuve, U Beller, W T Creasman, Apm Heintz, Hys Ngan, S Pecorelli. Int J Gynaecol Obstet 2006
243
33

Prevalence of BRCA1 and BRCA2 germ line mutations among women with carcinoma of the fallopian tube.
Danielle Vicus, Amy Finch, Ilana Cass, Barry Rosen, Joan Murphy, Isabel Fan, Robert Royer, John McLaughlin, Beth Karlan, Steven A Narod. Gynecol Oncol 2010
28
33

Six families prone to ovarian cancer.
J F Fraumeni, G W Grundy, E T Creagan, R B Everson. Cancer 1975
88
33


Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Theresa Wagner, Henry T Lynch, Judy E Garber, Mary B Daly, Claudine Isaacs, Olufunmilayo I Olopade, Susan L Neuhausen, Laura van 't Veer,[...]. J Clin Oncol 2005
268
33

Support of the 'fallopian tube hypothesis' in a prospective series of risk-reducing salpingo-oophorectomy specimens.
Welmoed Reitsma, Geertruida H de Bock, Jan C Oosterwijk, Joost Bart, Harry Hollema, Marian J E Mourits. Eur J Cancer 2013
73
33

Estrogen receptor status in BRCA1- and BRCA2-related breast cancer: the influence of age, grade, and histological type.
William D Foulkes, Kelly Metcalfe, Ping Sun, Wedad M Hanna, Henry T Lynch, Parviz Ghadirian, Nadine Tung, Olufunmilayo I Olopade, Barbara L Weber, Jane McLennan,[...]. Clin Cancer Res 2004
220
33

Hormone replacement therapy and life expectancy after prophylactic oophorectomy in women with BRCA1/2 mutations: a decision analysis.
Katrina Armstrong, J Sanford Schwartz, Thomas Randall, Stephen C Rubin, Barbara Weber. J Clin Oncol 2004
110
33

A cautious view of putative precursors of serous carcinomas in the fallopian tubes of BRCA mutation carriers.
Ilana Cass, Ann E Walts, Denise Barbuto, Jenny Lester, Beth Karlan. Gynecol Oncol 2014
20
33

Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management.
Henry T Lynch, Jane F Lynch, Patrick M Lynch, Thomas Attard. Fam Cancer 2008
130
33

The rate of the predominant Jewish mutations in the BRCA1, BRCA2, MSH2 and MSH6 genes in unselected Jewish endometrial cancer patients.
Frida Barak, Roni Milgrom, Yael Laitman, Ofer Gemer, Alex Rabinovich, Benjamin Piura, Eyal Anteby, Gilad Ben Baruch, Jacob Korach, Eitan Friedman. Gynecol Oncol 2010
15
33

Histopathological features of breast tumours in BRCA1, BRCA2 and mutation-negative breast cancer families.
Hannaleena Eerola, Päivi Heikkilä, Anitta Tamminen, Kristiina Aittomäki, Carl Blomqvist, Heli Nevanlinna. Breast Cancer Res 2005
70
33

Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome?
R Goshen, W Chu, L Elit, T Pal, J Hakimi, I Ackerman, A Fyles, M Mitchell, S A Narod. Gynecol Oncol 2000
96
33



Papillary peritoneal tumors in women.
A Foyle, M Al-Jabi, W T McCaughey. Am J Surg Pathol 1981
164
33

Clinical management of women at high risk of breast cancer.
Melanie Wuttke, Kelly-Anne Phillips. Curr Opin Obstet Gynecol 2015
9
33

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.
Timothy R Rebbeck, Henry T Lynch, Susan L Neuhausen, Steven A Narod, Laura Van't Veer, Judy E Garber, Gareth Evans, Claudine Isaacs, Mary B Daly, Ellen Matloff,[...]. N Engl J Med 2002
33

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
Noah D Kauff, Jaya M Satagopan, Mark E Robson, Lauren Scheuer, Martee Hensley, Clifford A Hudis, Nathan A Ellis, Jeff Boyd, Patrick I Borgen, Richard R Barakat,[...]. N Engl J Med 2002
868
33

Gynecologic Cancer InterGroup (GCIG) consensus review for uterine serous carcinoma.
Satoru Sagae, Nobuyuki Susumu, Akila N Viswanathan, Daisuke Aoki, Floor J Backes, Diane M Provencher, Michelle Vaughan, Carien L Creutzberg, Christian Kurzeder, Gunnar Kristensen,[...]. Int J Gynecol Cancer 2014
34
33

Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.
David W Kindelberger, Yonghee Lee, Alexander Miron, Michelle S Hirsch, Colleen Feltmate, Fabiola Medeiros, Michael J Callahan, Elizabeth O Garner, Robert W Gordon, Chandler Birch,[...]. Am J Surg Pathol 2007
715
33

Carcinoma of the Corpus Uteri.
W T Creasman, F Odicino, P Maisonneuve, M A Quinn, U Beller, J L Benedet, Apm Heintz, Hys Ngan, S Pecorelli. Int J Gynaecol Obstet 2006
350
33

Characterization of precursor lesions in the endometrium and fallopian tube epithelium of early-stage uterine serous carcinoma.
Mary C Tolcher, Elizabeth M Swisher, Fabiola Medeiros, Joema F Lima, Jodi L Hilderbrand, Janis L Donovan, Rochelle L Garcia, William A Cliby, Sean C Dowdy. Int J Gynecol Pathol 2015
15
33

Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers.
Andrea Eisen, Jan Lubinski, Jacek Gronwald, Pal Moller, Henry T Lynch, Jan Klijn, Charmaine Kim-Sing, Susan L Neuhausen, Lucy Gilbert, Parviz Ghadirian,[...]. J Natl Cancer Inst 2008
127
33

Effect of prevention strategies on survival and quality-adjusted survival of women with BRCA1/2 mutations: an updated decision analysis.
Victor R Grann, Judith S Jacobson, Dustin Thomason, Dawn Hershman, Daniel F Heitjan, Alfred I Neugut. J Clin Oncol 2002
107
33

The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study.
Mario E Beiner, Amy Finch, Barry Rosen, Jan Lubinski, Pal Moller, Parviz Ghadirian, Henry T Lynch, Eitan Friedman, Ping Sun, Steven A Narod. Gynecol Oncol 2007
83
33

BRCA2 germline mutation in a woman with uterine serous papillary carcinoma--case report.
Ofer Lavie, Alon Ben-Arie, Adalbert Pilip, Gad Rennert, Yoram Cohen, Beni Feiner, Ron Auslnader. Gynecol Oncol 2005
19
33


Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma.
Niloofar N Nik, Russell Vang, Ie-Ming Shih, Robert J Kurman. Annu Rev Pathol 2014
103
33

Prophylactic mastectomy for the prevention of breast cancer.
Liz Lostumbo, Nora E Carbine, Judi Wallace. Cochrane Database Syst Rev 2010
196
33

Update on raloxifene: mechanism of action, clinical efficacy, adverse effects, and contraindications.
Salvatore Gizzo, Carlo Saccardi, Tito Silvio Patrelli, Roberto Berretta, Giampiero Capobianco, Stefania Di Gangi, Antonio Vacilotto, Anna Bertocco, Marco Noventa, Emanuele Ancona,[...]. Obstet Gynecol Surv 2013
47
33

Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers.
Janice S Kwon, Anna Tinker, Gary Pansegrau, Jessica McAlpine, Melissa Housty, Mary McCullum, C Blake Gilks. Obstet Gynecol 2013
103
33

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
33

Prophylactic mastectomy: an appraisal.
Flora Zagouri, Dimosthenis T Chrysikos, Theodoros N Sergentanis, Georgia Giannakopoulou, Constantine G Zografos, Christos A Papadimitriou, George C Zografos. Am Surg 2013
4
33

Is uterine serous papillary carcinoma a BRCA1-related disease? Case report and review of the literature.
G Hornreich, U Beller, O Lavie, P Renbaum, Y Cohen, E Levy-Lahad. Gynecol Oncol 1999
65
33

Familial association of breast/ovarian carcinoma.
H T Lynch, R E Harris, H A Guirgis, K Maloney, L L Carmody, J F Lynch. Cancer 1978
147
33

Cancer Incidence in BRCA1 mutation carriers.
Deborah Thompson, Douglas F Easton. J Natl Cancer Inst 2002
728
33

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
33

Papillary serous carcinoma of the uterine cervix: a clinicopathologic study of 17 cases.
C Zhou, C B Gilks, M Hayes, P B Clement. Am J Surg Pathol 1998
48
33

The origin of serous ovarian cancer may be found in the uterus: a novel hypothesis.
Leon Massuger, Thijs Roelofsen, Maaike van Ham, Johan Bulten. Med Hypotheses 2010
26
33

The endometrial effects of SERMs.
A Cano, C Hermenegildo. Hum Reprod Update 2000
30
33

Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations.
R P Zweemer, P J van Diest, R H Verheijen, A Ryan, J J Gille, R H Sijmons, I J Jacobs, F H Menko, P Kenemans. Gynecol Oncol 2000
135
33

Phenotypic heterogeneity of hereditary gynecologic cancers: a report from the Creighton hereditary cancer registry.
Murray Joseph Casey, Chhanda Bewtra, Henry T Lynch, Carrie Snyder, Mark Stacy, Patrice Watson. Fam Cancer 2013
9
33

BRCA germline mutations in Jewish women with uterine serous papillary carcinoma.
Ofer Lavie, Gila Hornreich, Alon Ben-Arie, Gad Rennert, Yoram Cohen, Rehuven Keidar, Shlomi Sagi, Efrat Levy Lahad, Ron Auslander, Uzi Beller. Gynecol Oncol 2004
78
33

Hereditary factors in cancer. Study of two large midwestern kindreds.
H T Lynch, M W Shaw, C W Magnuson, A L Larsen, A J Krush. Arch Intern Med 1966
292
33

Familial peritoneal ovarian carcinomatosis: a new clinical entity?
H T Lynch, C Bewtra, J F Lynch. Med Hypotheses 1986
17
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.